on BIOSYNEX (EPA:ALBIO)
Brigitte Geny resigns from the Board of Directors of BIOSYNEX
On December 30, 2025, the Board of Directors of BIOSYNEX announced the resignation of Ms. Brigitte Geny from her position as an independent director for personal reasons. Her departure will take effect on January 19, 2026, thus reducing the number of directors to six.
The Board expressed its gratitude to Ms. Geny for her commitment and contribution to the Board's work. This transition comes as the company prepares its upcoming financial communications, including the announcement of its 2025 annual revenue scheduled for January 15, 2026.
BIOSYNEX, based in Alsace, is a major player in the rapid diagnostic testing sector, developing and marketing innovative solutions worldwide. The company continues to expand its international reach through a dynamic growth strategy.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BIOSYNEX news